Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $340.61 | $7.42 | 4,488.91% | 6,812.20x | 327.48x | 7.55x | 9.14x | 18.21x | $529.27M | 1.41% | $4.13B | 37.48 | $35.60B | 111.93 | ||
| NVO | NOVO NORDISK A S | $49.35 | $154.43 | -68.04% | 13.72x | 2.06x | 4.51x | 8.38x | 0.14x | $9.34B | 4.26% | $26.18B | 5.89 | $229.94B | 9.27 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.40 | $33.33 | 138.21% | 79.40x | 78.03x | 11.09x | 13.22x | 1.11x | $162.57M | 1.98% | $631.90M | 6.10 | $8.23B | 124.79 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $451.23 | $29.59 | 1,424.79% | 1,455.58x | 309.93x | 18.48x | 254.87x | 6.20x | $221.36M | 0.37% | $233.89M | 1.78 | $61.34B | 403.73 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.75 | $5.10 | -65.68% | 25.00x | 13.33x | 2.24x | 2.66x | 0.14x | -$11.69M | -8.40% | $52.91M | 0.67 | $135.27M | 15.25 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.60 | $11.54 | -25.44% | 17.92x | 7.01x | 5.70x | 3.64x | 0.38x | -$23.64M | -4.92% | $133.17M | 2.38 | $492.44M | 7.33 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.52 | $15.43 | 175.57% | 86.78x | 40.18x | 5.31x | 6.02x | 1.30x | $101.73M | 3.20% | $535.38M | 7.17 | $3.06B | 57.07 | ||
| GMAB | GENMAB A | $32.36 | $116.96 | -72.33% | 13.81x | 1.87x | 5.83x | 3.61x | 0.12x | $1.19B | 5.75% | $5.75B | 8.96 | $19.16B | 9.57 | ||
| ARGX | ARGENX SE | $911.98 | $263.29 | 246.37% | 36.44x | 54.50x | 29,418.71x | 7.76x | 3.05x | $467.72M | 0.84% | $7.17B | 117.50 | $53.26B | 65.65 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $203.18 | $62.78 | 223.62% | 87.96x | 29.02x | 15.83x | 4.21x | 1.58x | $30.76M | 0.77% | $950.17M | 48.53 | $4.31B | 41.84 | ||
| VCEL | VERICEL CORP | $40.25 | $7.43 | 441.62% | 154.81x | 179.37x | 7.86x | 6.32x | 2.61x | $20.38M | 1.00% | $321.86M | 6.38 | $2.03B | 69.37 | ||
| TECH | BIO-TECHNE CORP | $64.51 | $16.80 | 284.06% | 129.02x | 31.57x | 8.24x | 5.11x | 1.78x | $224.06M | 2.23% | $1.97B | 12.65 | $10.30B | 46.63 | ||
| RPRX | ROYALTY PHARMA PLC | $40.02 | $42.57 | -6.00% | 22.74x | 8.73x | 7.36x | 2.40x | 0.48x | $2.11B | 12.22% | $9.62B | 22.28 | $31.11B | 29.79 | ||
| KRYS | KRYSTAL BIOTECH INC | $218.00 | $85.82 | 154.01% | 31.59x | 42.80x | 16.91x | 5.56x | 1.86x | $166.02M | 2.63% | $1.14B | 39.30 | $5.94B | 30.72 | ||
| CRMD | CORMEDIX INC | $9.81 | $16.98 | -42.22% | 4.32x | 4.63x | 3.48x | 2.07x | 1.09x | $74.42M | 9.99% | $374.13M | 4.93 | $873.35M | 7.78 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.75 | $0.87 | 788.57% | 110.71x | 73.53x | 6.56x | 7.33x | 6.50x | $3.05M | 0.44% | $101.92M | 1.12 | $707.34M | 53.47 | ||
| VCYT | VERACYTE INC | $47.34 | $9.09 | 420.89% | 121.38x | 118.50x | 7.53x | 2.98x | 2.67x | $98.21M | 2.64% | $1.26B | 15.98 | $3.47B | 60.80 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.93 | $42.85 | 30.52% | 20.56x | 18.42x | 3.47x | 1.77x | 0.80x | $832.13M | 7.75% | $6.06B | 31.54 | $10.09B | 13.06 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.40 | $78.56 | -9.11% | 14.60x | 11.37x | 6.73x | 16.66x | 0.55x | $602.40M | 7.20% | $503.92M | 4.30 | $9.49B | 11.22 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.29 | $40.53 | -12.92% | 10.93x | 10.80x | 2.46x | 2.43x | 0.63x | $296.89M | 14.62% | $835.12M | 14.51 | $1.55B | 5.76 | ||
| ADMA | ADMA BIOLOGICS INC | $19.18 | $9.50 | 101.99% | 21.80x | 31.69x | 9.37x | 10.59x | 1.72x | $40.73M | 0.89% | $431.19M | 1.81 | $4.58B | 26.59 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.77 | $2.36 | 187.19% | 25.07x | 46.09x | 4.33x | 7.64x | 3.46x | $21.15M | 3.91% | $70.68M | 0.89 | $479.05M | 21.11 | ||
| INVA | INNOVIVA INC | $21.73 | $18.59 | 16.87% | 11.50x | 18.26x | 3.86x | 1.61x | 1.13x | $196.54M | 13.10% | $1.01B | 14.63 | $1.41B | 6.55 | ||
| INCY | INCYTE CORP | $104.46 | $68.42 | 52.68% | 17.29x | 15.00x | 4.25x | 4.41x | 1.23x | $1.20B | 5.86% | $4.65B | 23.77 | $18.09B | 10.75 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.12 | $7.29 | 121.07% | 27.79x | 24.38x | 7.99x | 5.81x | 1.60x | $119.87M | 5.64% | $365.77M | 2.78 | $2.13B | 20.58 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $433.61 | $176.68 | 145.42% | 30.30x | 23.59x | 9.45x | 6.35x | 1.81x | $3.34B | 3.01% | $17.32B | 67.76 | $106.91B | 22.93 | ||
| EXEL | EXELIXIS INC | $44.17 | $27.85 | 58.63% | 17.96x | 18.43x | 5.18x | 5.48x | 1.28x | $779.77M | 6.58% | $2.16B | 8.05 | $11.64B | 12.55 | ||
| UTHR | UNITED THERAPEUTICS CORP | $486.00 | $198.17 | 145.24% | 17.06x | 17.31x | 6.80x | 3.18x | 6.60x | $1.12B | 5.27% | $6.59B | 150.46 | $19.59B | 11.05 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $780.19 | $357.39 | 118.30% | 17.96x | 18.25x | 5.67x | 2.65x | 3.04x | $4.22B | 5.22% | $30.96B | 298.82 | $82.20B | 14.39 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.41 | $11.10 | 110.99% | 13.08x | 15.74x | 4.96x | 3.13x | 22.08x | $234.54M | 8.17% | $920.25M | 7.51 | $2.19B | 6.76 | ||
| MDXG | MIMEDX GROUP INC | $6.88 | $3.23 | 113.15% | 24.57x | 15.87x | 2.59x | 4.26x | 1.68x | $66.82M | 6.56% | $238.95M | 1.61 | $895.07M | 12.93 | ||
| MNKD | MANNKIND CORP | $5.35 | $1.30 | 310.07% | 53.50x | 56.49x | 5.23x | -36.87x | 2.88x | $43.39M | 2.64% | -$44.55M | -0.15 | $1.88B | 25.62 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.